Consolidated Investment Group LLC Sells 1,400 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Consolidated Investment Group LLC cut its position in UnitedHealth Group Incorporated (NYSE:UNH) by 8.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 15,135 shares of the healthcare conglomerate’s stock after selling 1,400 shares during the quarter. UnitedHealth Group accounts for about 1.2% of Consolidated Investment Group LLC’s holdings, making the stock its 20th biggest holding. Consolidated Investment Group LLC’s holdings in UnitedHealth Group were worth $7,707,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of UNH. BigSur Wealth Management LLC raised its position in shares of UnitedHealth Group by 4.1% during the second quarter. BigSur Wealth Management LLC now owns 4,718 shares of the healthcare conglomerate’s stock worth $2,403,000 after acquiring an additional 187 shares during the last quarter. Kraft Asset Management LLC grew its stake in UnitedHealth Group by 24.1% during the second quarter. Kraft Asset Management LLC now owns 546 shares of the healthcare conglomerate’s stock worth $278,000 after purchasing an additional 106 shares during the period. West Coast Financial LLC grew its stake in UnitedHealth Group by 1.4% during the second quarter. West Coast Financial LLC now owns 22,815 shares of the healthcare conglomerate’s stock worth $11,619,000 after purchasing an additional 316 shares during the period. Cidel Asset Management Inc. grew its stake in UnitedHealth Group by 4.4% during the second quarter. Cidel Asset Management Inc. now owns 4,740 shares of the healthcare conglomerate’s stock worth $2,414,000 after purchasing an additional 200 shares during the period. Finally, Sunpointe LLC grew its stake in UnitedHealth Group by 3.7% during the second quarter. Sunpointe LLC now owns 2,761 shares of the healthcare conglomerate’s stock worth $1,406,000 after purchasing an additional 98 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

UNH has been the subject of several recent analyst reports. TD Cowen raised their target price on UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. JPMorgan Chase & Co. raised their price objective on UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research note on Thursday, May 30th. Wells Fargo & Company raised their price objective on UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Tuesday, August 13th. Finally, Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and raised their price objective for the company from $481.00 to $647.00 in a research note on Wednesday, July 17th. One analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Buy” and an average price target of $614.17.

UnitedHealth Group Stock Performance

Shares of UNH traded up $1.87 during mid-day trading on Tuesday, hitting $580.65. The stock had a trading volume of 1,638,356 shares, compared to its average volume of 4,197,138. The firm has a market cap of $536.18 billion, a P/E ratio of 35.56, a PEG ratio of 1.61 and a beta of 0.59. The business has a fifty day moving average price of $531.06 and a 200-day moving average price of $507.93. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $591.54.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. During the same period in the previous year, the company posted $6.14 EPS. The firm’s revenue for the quarter was up 6.4% compared to the same quarter last year. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.45%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s payout ratio is 51.34%.

Insider Buying and Selling

In other news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is owned by company insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.